PRKN and Glucose intolerance: Parkin-KO mice have been reported to have exacerbated glucose intolerance and further impaired insulin release after treatment with streptozotocin and PFT-α, which is an inhibitor of p53, compared to wild-type mice43, suggesting a protective role of PARKIN-mediated mitophagy in stressed β-cells.